Status:
COMPLETED
Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis
Lead Sponsor:
Vanderbilt University
Collaborating Sponsors:
Takeda
Conditions:
Suspected Eosinophilic Esophagitis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study is for patients who have had a food impaction and/or difficulty swallowing, who are scheduled to have endoscopy, biopsy and possibly dilatation (stretching) of the esophagus. Standard trea...
Detailed Description
Eosinophilic esophagitis (EE) is an inflammatory condition of the esophagus found in the pediatric and adult population. It is characterized by an intense eosinophilic infiltration of the surface lini...
Eligibility Criteria
Inclusion
- Male and female volunteers ≥18 years old.
- Patients with known or suspected Eosinophilic Esophagitis.
- Patients undergoing upper endoscopy for recent food impaction or complaint of dysphagia.
Exclusion
- Use of oral corticosteroids.
- Significant medical conditions that in the investigator's judgment would compromise the subject's health and safety.
- Contraindication to esophageal dilation based on investigator's judgment.
- Esophageal motility abnormalities not thought to be related to Eosinophilic Esophagitis.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00880906
Start Date
August 1 2008
End Date
December 1 2013
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt Unversity Medical Center Department of Gastroenterology
Nashville, Tennessee, United States, 37212